StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
21
This year
1
Publishing Date
2024 - 02 - 28
1
2023 - 11 - 02
1
2023 - 10 - 13
1
2023 - 09 - 18
1
2023 - 08 - 07
1
2023 - 08 - 03
1
2023 - 05 - 04
1
2023 - 02 - 28
1
2023 - 01 - 08
1
2023 - 01 - 02
1
2022 - 11 - 03
1
2022 - 02 - 28
1
2021 - 12 - 15
1
2021 - 11 - 02
1
2021 - 10 - 26
1
2021 - 08 - 05
1
2021 - 08 - 03
1
2021 - 05 - 06
1
2021 - 04 - 27
1
2021 - 03 - 16
1
2021 - 01 - 19
1
Sector
Health technology
21
Professional, scientific, and technical services
2
Tags
Announces collaboration
1
Antibody
1
Business
4
Cancer
2
Cell
1
Ces
1
Collaboration
1
Companies
2
Earnings
3
Endocrine
1
Events
1
Expected
1
Fda
1
Financial
6
Financial results
8
Growth
4
Liver
2
Market
2
N/a
17
Pancreatic
3
Potential
1
Results
12
Review
1
T-cell
1
Treatment
1
Tumor
1
Update
6
Year
3
Entities
Abbott laboratories
56
Abbvie inc.
111
Abcellera biologics inc
12
Ac immune sa
35
Adc therapeutics sa
13
Agios pharmaceuticals, inc.
10
Akouos, inc.
11
Alnylam pharmaceuticals, inc.
38
Amgen inc.
88
Astellas pharma inc
25
Astrazeneca plc
98
Aveo pharmaceuticals, inc.
25
Baxter international inc.
14
Becton, dickinson and company
21
Beigene, ltd.
19
Biocryst pharmaceuticals, inc.
13
Biogen inc.
20
Biontech se
14
Blueprint medicines corporation
20
Boston scientific corporation
10
Bristol-myers squibb company
106
Clovis oncology, inc.
20
Eli lilly and company
1709
Epizyme, inc.
20
Exelixis, inc.
13
Gilead sciences, inc.
35
Glaxosmithkline plc
107
Hutchison china meditech limited
11
Icon plc
10
Illumina, inc.
15
Incyte corporation
207
Insulet corporation
14
Johnson & johnson
175
Karyopharm therapeutics inc.
20
Ligand pharmaceuticals incorporated
10
Medtronic plc
14
Merus n.v.
21
Nektar therapeutics
10
Novartis ag
138
Novo nordisk a/s
83
Omeros corporation
15
Otonomy, inc.
13
Pfizer, inc.
80
Point biopharma global inc
10
Precision biosciences, inc.
11
Proqr therapeutics n.v.
17
Regeneron pharmaceuticals, inc.
36
Rigel pharmaceuticals, inc.
41
Sanofi
335
Takeda pharmaceutical company limited
42
Terumo corp
14
Teva pharmaceutical industries ltd
61
Thermo fisher scientific inc
14
Ucb s.a.
11
United therapeutics corporation
14
Verastem, inc.
11
Vertex pharmaceuticals incorporated
12
Veru inc.
57
Viatris inc.
18
Y-mabs therapeutics, inc.
18
Symbols
ABCL
2
ABCM
1
ABCZF
1
ABSI
1
ACRS
1
ADMA
1
AFMD
2
AGEN
3
ALGS
1
ALPMF
2
ALPMY
2
ALPN
1
AMGN
2
APRE
1
APVO
2
AQST
1
ARDX
1
ASMB
1
ATAI
1
ATHA
1
AVXL
1
AZN
1
AZNCF
1
BCYC
1
BLU
1
BMEA
1
BNTX
4
CALA
1
CALT
1
CCCC
2
CLSD
1
CMPS
1
CMRX
1
COGT
1
CRVS
1
CVAC
1
DTIL
3
FHTX
1
FSTX
2
FUSN
1
GILD
1
GRTX
2
GSK
1
HBIO
1
HRMY
1
HROW
1
ICLR
1
INCY
14
INZY
1
IOVA
1
JNJ
1
KALA
1
LLY
21
MREO
2
MRUS
82
PRQR
2
RCUS
2
RIGL
4
SNY
5
SNYNF
4
Exchanges
Nasdaq
21
Nyse
21
Crawled Date
2024 - 02 - 28
1
2023 - 11 - 02
1
2023 - 10 - 13
1
2023 - 09 - 18
1
2023 - 08 - 07
1
2023 - 08 - 03
1
2023 - 05 - 04
1
2023 - 02 - 28
1
2023 - 01 - 08
1
2023 - 01 - 02
1
2022 - 11 - 03
1
2022 - 02 - 28
1
2021 - 12 - 15
1
2021 - 11 - 02
1
2021 - 10 - 26
1
2021 - 08 - 05
1
2021 - 08 - 03
1
2021 - 05 - 06
1
2021 - 04 - 27
1
2021 - 03 - 16
1
2021 - 01 - 19
1
Crawled Time
11:00
1
12:00
3
12:07
1
13:00
1
15:30
1
16:00
1
16:20
1
20:00
2
21:00
7
22:00
2
23:00
1
Source
www.biospace.com
4
www.globenewswire.com
12
www.prnewswire.com
5
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
entities :
Merus n.v.
symbols :
Lly
save search
Merus Announces Financial Results for the Fourth Quarter and Full Year 2023 and Provides Business Update
Published:
2024-02-28
(Crawled : 21:00)
- globenewswire.com
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
-4.14%
|
O:
-0.6%
H:
0.45%
C:
0.08%
MRUS
|
$39.83
-1.58%
-1.61%
800K
|
Health Technology
|
-18.25%
|
O:
2.3%
H:
0.58%
C:
-2.69%
INCY
|
$52.3
-0.98%
-0.99%
2.2M
|
Health Technology
|
-12.72%
|
O:
0.38%
H:
0.0%
C:
-3.07%
business
year
update
financial
results
Merus Announces Financial Results for the Third Quarter 2023 and Provides Business Update
Published:
2023-11-02
(Crawled : 20:00)
- globenewswire.com
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
25.88%
|
O:
0.97%
H:
0.0%
C:
0.0%
MRUS
|
$39.83
-1.58%
-1.61%
800K
|
Health Technology
|
81.45%
|
O:
3.51%
H:
9.56%
C:
9.56%
INCY
|
$52.3
-0.98%
-0.99%
2.2M
|
Health Technology
|
-3.0%
|
O:
0.52%
H:
1.38%
C:
1.11%
business
update
financial
results
New FDA Designations Accelerate Progress in Pancreatic Cancer Treatments: A Year in Review
Published:
2023-10-13
(Crawled : 13:00)
- prnewswire.com
PYXS
|
$4.155
-8.28%
-9.03%
670K
|
Professional, Scientific, and T...
|
113.33%
|
O:
0.0%
H:
2.56%
C:
2.56%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
19.36%
|
O:
1.15%
H:
0.0%
C:
0.0%
ONCY
|
$1.045
-3.24%
-3.35%
180K
|
Health Technology
|
-40.22%
|
O:
-1.63%
H:
4.97%
C:
2.76%
MRUS
|
$39.83
-1.58%
-1.61%
800K
|
Health Technology
|
88.85%
|
O:
0.47%
H:
1.7%
C:
-0.38%
AZN
|
News
|
$68.56
0.29%
0.29%
4.7M
|
Health Technology
|
0.65%
|
O:
-0.59%
H:
0.62%
C:
-0.56%
fda
year
review
cancer
pancreatic
Head and Neck Squamous Cell Carcinoma Market to Witness Upsurge in Growth by 2032, Assesses DelveInsight | Key Companies in the Market - Pfizer, Merck, Eisai, AstraZeneca, Innate, Roche, GlaxoSmithKline, BeiGene, IO Biotech, Incyte
Published:
2023-09-18
(Crawled : 21:00)
- prnewswire.com
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-15.73%
|
O:
-0.62%
H:
0.0%
C:
-1.16%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
27.14%
|
O:
0.06%
H:
1.19%
C:
0.58%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-14.72%
|
O:
-0.09%
H:
1.16%
C:
1.16%
MRUS
|
$39.83
-1.58%
-1.61%
800K
|
Health Technology
|
60.01%
|
O:
-0.16%
H:
2.46%
C:
0.56%
KURA
|
$17.55
-0.74%
-0.74%
1.3M
|
Health Technology
|
82.79%
|
O:
-0.1%
H:
2.4%
C:
0.52%
IOVA
|
News
M
|
$11.32
-3.41%
-3.53%
5.3M
|
Health Technology
|
90.73%
|
O:
-0.51%
H:
1.5%
C:
-7.97%
INCY
|
$52.3
-0.98%
-0.99%
2.2M
|
Health Technology
|
-12.03%
|
O:
0.03%
H:
2.18%
C:
1.8%
FUSN
|
$21.26
0.05%
0.05%
440K
|
Health Technology
|
702.26%
|
O:
0.0%
H:
0.41%
C:
-2.26%
CALT
|
$17.65
-2.4%
4K
|
Health Technology
|
8.28%
|
O:
-6.2%
H:
4.2%
C:
0.0%
BNTX
|
$86.82
0.75%
0.75%
1.6M
|
Health Technology
|
-20.39%
|
O:
-0.01%
H:
1.99%
C:
1.28%
companies
cell
growth
market
Merus Announces Financial Results for the Second Quarter 2023 and Provides Business Update
Published:
2023-08-07
(Crawled : 21:00)
- globenewswire.com
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
59.95%
|
O:
11.43%
H:
6.32%
C:
3.08%
MRUS
|
$39.83
-1.58%
-1.61%
800K
|
Health Technology
|
58.92%
|
O:
3.79%
H:
1.72%
C:
-11.69%
INCY
|
$52.3
-0.98%
-0.99%
2.2M
|
Health Technology
|
-17.73%
|
O:
2.58%
H:
0.41%
C:
-1.13%
business
update
financial
results
Pancreatic Endocrine Tumor Market is Expected to Expand at a Healthy Growth Rate by 2032, Assesses DelveInsight | Key Companies - Merck, Theradex, SynerGene, Mirati, Novartis, Syntrix Biosystems, Eli Lilly, Boehringer Ingelheim
Published:
2023-08-03
(Crawled : 21:00)
- prnewswire.com
BMEA
|
$10.87
-2.6%
-2.67%
1.3M
|
Professional, Scientific, and T...
|
-42.83%
|
O:
-0.11%
H:
4.35%
C:
1.85%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
60.88%
|
O:
-0.53%
H:
0.0%
C:
0.0%
RCUS
4
|
$14.59
-1.69%
0.0%
600K
|
Health Technology
|
-23.33%
|
O:
0.11%
H:
1.42%
C:
-0.16%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-7.71%
|
O:
2.43%
H:
0.0%
C:
0.0%
MRUS
|
$39.83
-1.58%
-1.61%
800K
|
Health Technology
|
53.0%
|
O:
-0.23%
H:
1.85%
C:
0.15%
INCY
|
$52.3
-0.98%
-0.99%
2.2M
|
Health Technology
|
-19.44%
|
O:
-0.8%
H:
0.99%
C:
-1.29%
GRTX
|
$0.1833
-1.45%
-1.47%
800K
|
Health Technology
|
-91.93%
|
O:
0.45%
H:
4.02%
C:
0.45%
BNTX
|
$86.82
0.75%
0.75%
1.6M
|
Health Technology
|
-18.6%
|
O:
-0.01%
H:
1.23%
C:
-0.15%
AGEN
|
$5.3
6.64%
6.23%
1.5M
|
Health Technology
|
266.21%
|
O:
0.69%
H:
3.08%
C:
0.0%
companies
expected
pancreatic
tumor
endocrine
growth
market
Merus Announces Financial Results for the First Quarter 2023 and Provides Business Update
Published:
2023-05-04
(Crawled : 20:00)
- globenewswire.com
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
69.52%
|
O:
-0.08%
H:
0.74%
C:
-0.07%
MRUS
|
$39.83
-1.58%
-1.61%
800K
|
Health Technology
|
111.64%
|
O:
4.36%
H:
8.41%
C:
5.96%
INCY
|
$52.3
-0.98%
-0.99%
2.2M
|
Health Technology
|
-20.91%
|
O:
0.85%
H:
1.46%
C:
-0.28%
business
update
financial
results
Merus Announces Financial Results for the Fourth Quarter and Full Year 2022 and Provides Business Update
Published:
2023-02-28
(Crawled : 23:00)
- globenewswire.com
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
133.38%
|
O:
-0.39%
H:
2.23%
C:
1.35%
MRUS
|
$39.83
-1.58%
-1.61%
800K
|
Health Technology
|
108.76%
|
O:
4.04%
H:
1.21%
C:
-1.92%
INCY
|
$52.3
-0.98%
-0.99%
2.2M
|
Health Technology
|
-32.0%
|
O:
0.04%
H:
1.31%
C:
1.06%
year
financial
update
Merus Provides 2023 Outlook
Published:
2023-01-08
(Crawled : 16:20)
- globenewswire.com
MRUS
|
$39.83
-1.58%
-1.61%
800K
|
Health Technology
|
Email alert
Add to watchlist
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
Email alert
Add to watchlist
Propulsion of Pancreatic Cancer Pipeline as Novel and Extensive 170+ Therapies Likely to Enter in the Treatment Domain | DelveInsight
Published:
2023-01-02
(Crawled : 16:00)
- prnewswire.com
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
Email alert
Add to watchlist
INCY
|
$52.3
-0.98%
-0.99%
2.2M
|
Health Technology
|
Email alert
Add to watchlist
RCUS
4
|
$14.59
-1.69%
0.0%
600K
|
Health Technology
|
Email alert
Add to watchlist
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
Email alert
Add to watchlist
QLGN
|
$0.301
-3.43%
-3.55%
30K
|
Health Technology
|
Email alert
Add to watchlist
BNTX
|
$86.82
0.75%
0.75%
1.6M
|
Health Technology
|
Email alert
Add to watchlist
AGEN
|
$5.3
6.64%
6.23%
1.5M
|
Health Technology
|
Email alert
Add to watchlist
MRUS
|
$39.83
-1.58%
-1.61%
800K
|
Health Technology
|
Email alert
Add to watchlist
GRTX
|
$0.1833
-1.45%
-1.47%
800K
|
Health Technology
|
Email alert
Add to watchlist
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
Email alert
Add to watchlist
treatment
cancer
pancreatic
Merus Announces Financial Results for the Third Quarter and Provides Business Update
Published:
2022-11-03
(Crawled : 12:00)
- globenewswire.com
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
104.62%
|
O:
-0.25%
H:
2.48%
C:
2.15%
MRUS
|
$39.83
-1.58%
-1.61%
800K
|
Health Technology
|
95.34%
|
O:
-38.62%
H:
31.1%
C:
22.14%
INCY
|
$52.3
-0.98%
-0.99%
2.2M
|
Health Technology
|
-32.15%
|
O:
-0.86%
H:
1.31%
C:
0.54%
financial
update
Merus Announces Financial Results for the Fourth Quarter and Full Year 2021 and Provides Business Update
Published:
2022-02-28
(Crawled : 22:00)
- globenewswire.com
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
196.93%
|
O:
1.26%
H:
0.0%
C:
0.0%
MRUS
|
$39.83
-1.58%
-1.61%
800K
|
Health Technology
|
41.72%
|
O:
1.03%
H:
4.76%
C:
0.35%
INCY
|
$52.3
-0.98%
-0.99%
2.2M
|
Health Technology
|
-22.79%
|
O:
0.44%
H:
2.1%
C:
0.88%
financial results
ces
results
Lilly Highlights Innovation-based Growth Strategy and Pipeline Developments; Announces 2022 Financial Guidance at Investment Community Meeting
Published:
2021-12-15
(Crawled : 15:30)
- biospace.com/
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
191.25%
|
O:
4.7%
H:
0.0%
C:
0.0%
RIGL
|
$1.07
1.91%
1.87%
810K
|
Health Technology
|
-54.24%
|
O:
0.42%
H:
5.91%
C:
5.06%
PRQR
|
News
|
$1.965
5.65%
5.34%
130K
|
Health Technology
|
-69.8%
|
O:
0.61%
H:
0.0%
C:
0.0%
NKTR
|
News
|
$1.265
-4.17%
-4.35%
4.7M
|
Health Technology
|
-90.22%
|
O:
0.16%
H:
2.52%
C:
2.05%
MRUS
|
$39.83
-1.58%
-1.61%
800K
|
Health Technology
|
41.62%
|
O:
-0.71%
H:
9.28%
C:
9.24%
FHTX
|
$5.335
-3.53%
-3.66%
120K
|
Health Technology
|
-70.07%
|
O:
-1.75%
H:
9.43%
C:
1.03%
growth
Merus Announces Regulatory Update on Zenocutuzumab, Financial Results for the Third Quarter and Provides Business Update
Published:
2021-11-02
(Crawled : 21:00)
- globenewswire.com
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
189.07%
|
O:
2.72%
H:
0.0%
C:
0.0%
MRUS
|
$39.83
-1.58%
-1.61%
800K
|
Health Technology
|
30.52%
|
O:
1.64%
H:
6.45%
C:
2.0%
INCY
|
$52.3
-0.98%
-0.99%
2.2M
|
Health Technology
|
-17.53%
|
O:
1.76%
H:
0.0%
C:
0.0%
financial results
results
Lilly Reports Robust Third-Quarter 2021 Financial Results as Pipeline Success Strengthens Future Growth Potential
Published:
2021-10-26
(Crawled : 11:00)
- biospace.com/
ABCL
|
$3.88
-0.77%
-0.77%
980K
|
|
-76.5%
|
O:
-1.7%
H:
0.0%
C:
0.0%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
196.39%
|
O:
-0.73%
H:
0.0%
C:
0.0%
RIGL
|
$1.07
1.91%
1.87%
810K
|
Health Technology
|
-66.36%
|
O:
0.0%
H:
0.0%
C:
0.0%
PRQR
|
News
|
$1.965
5.65%
5.34%
130K
|
Health Technology
|
-73.36%
|
O:
-0.13%
H:
0.0%
C:
0.0%
DTIL
|
$9.75
-9.05%
-9.95%
170K
|
Health Technology
|
0.93%
|
O:
-0.31%
H:
0.0%
C:
0.0%
MRUS
|
$39.83
-1.58%
-1.61%
800K
|
Health Technology
|
42.23%
|
O:
-0.82%
H:
0.0%
C:
0.0%
financial results
potential
results
growth
Merus Announces Financial Results for the Second Quarter and Provides Business Update
Published:
2021-08-05
(Crawled : 21:00)
- globenewswire.com
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
174.92%
|
O:
-0.18%
H:
0.0%
C:
0.0%
MRUS
|
$39.83
-1.58%
-1.61%
800K
|
Health Technology
|
110.63%
|
O:
0.42%
H:
4.79%
C:
4.58%
INCY
|
$52.3
-0.98%
-0.99%
2.2M
|
Health Technology
|
-31.94%
|
O:
-0.12%
H:
0.31%
C:
-0.69%
financial results
results
Lilly Delivers Strong Second-Quarter 2021 Financial Results, Updates 2021 Financial Guidance
Published:
2021-08-03
(Crawled : 12:00)
- biospace.com/
ABCL
|
$3.88
-0.77%
-0.77%
980K
|
|
-75.54%
|
O:
1.14%
H:
0.0%
C:
-1.56%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
194.53%
|
O:
-0.75%
H:
5.97%
C:
4.59%
RIGL
|
$1.07
1.91%
1.87%
810K
|
Health Technology
|
-73.13%
|
O:
0.5%
H:
0.5%
C:
-6.44%
DTIL
|
$9.75
-9.05%
-9.95%
170K
|
Health Technology
|
-1.91%
|
O:
-0.1%
H:
0.0%
C:
-1.21%
MRUS
|
$39.83
-1.58%
-1.61%
800K
|
Health Technology
|
123.4%
|
O:
0.9%
H:
1.45%
C:
0.67%
financial results
results
liver
Merus Announces Financial Results for the First Quarter and Provides Business Update
Published:
2021-05-06
(Crawled : 22:00)
- globenewswire.com
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
274.6%
|
O:
0.48%
H:
0.74%
C:
0.31%
MRUS
|
$39.83
-1.58%
-1.61%
800K
|
Health Technology
|
96.21%
|
O:
0.59%
H:
4.07%
C:
-0.49%
financial results
results
Lilly Delivers First-Quarter 2021 Financial Results, Adjusts 2021 Financial Guidance
Published:
2021-04-27
(Crawled : 12:00)
- biospace.com/
GSK
|
News
|
$39.75
1.22%
0.0%
1.6M
|
Health Technology
|
5.21%
|
O:
-0.03%
H:
0.26%
C:
-0.11%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
287.94%
|
O:
-1.72%
H:
1.02%
C:
-0.97%
VIR
|
$7.96
0.0%
1.1M
|
Health Technology
|
-84.41%
|
O:
0.0%
H:
0.16%
C:
-3.69%
RIGL
|
$1.07
1.91%
1.87%
810K
|
Health Technology
|
-72.31%
|
O:
1.54%
H:
0.25%
C:
-3.28%
DTIL
|
$9.75
-9.05%
-9.95%
170K
|
Health Technology
|
-1.42%
|
O:
0.4%
H:
3.33%
C:
-1.11%
MRUS
|
$39.83
-1.58%
-1.61%
800K
|
Health Technology
|
70.42%
|
O:
-0.64%
H:
0.0%
C:
-2.8%
financial results
results
liver
Merus Announces Financial Results for the Fourth Quarter and Full Year 2020 and Provides Business Update
Published:
2021-03-16
(Crawled : 21:00)
- globenewswire.com
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
280.47%
|
O:
-0.61%
H:
0.05%
C:
-1.58%
MRUS
|
$39.83
-1.58%
-1.61%
800K
|
Health Technology
|
70.57%
|
O:
6.43%
H:
0.0%
C:
-8.45%
INCY
|
$52.3
-0.98%
-0.99%
2.2M
|
Health Technology
|
-34.79%
|
O:
-1.86%
H:
2.91%
C:
1.79%
financial results
results
← Previous
1
2
Next →
Gainers vs Losers
67%
33%
Top 10 Gainers
RCON
|
$0.1112
13.01%
21.28%
1.7M
|
Distribution Services
GBR
|
$1.42
31.48%
11.27%
990K
|
Energy Minerals
KUKE
|
$2.88
2.49%
7.64%
360K
|
SYY
|
$76.73
1.44%
5.49%
2.5M
|
Distribution Services
TWI
|
$11.53
0.96%
4.94%
330K
|
Producer Manufacturing
BTCM
|
$1.99
-6.13%
4.52%
75K
|
Arts, Entertainment, and Recrea...
MPLN
|
$0.6502
-11.74%
4.51%
2.2M
|
Finance
CXM
4
|
$11.34
-0.44%
4.27%
1.7M
|
Information
UHS
|
$157.47
2.49%
4.13%
900K
|
Health Services
PVL
4
|
$1.47
-0.68%
4.08%
77K
|
Energy Minerals
Your saved searches
Save your searches and get alerts when important news are released.